Articles & News
NeuroAiD - Clinical Data for Stroke
Video Interview of Professor Ramani
NeuroAiD(TM)II holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic...
SINGAPORE, Jan. 12, 2022 /PRNewswire/ -- Moleac is pleased to announce the release of the ATHENE study results, published in the Journal of the American Medical Director Association (JAMDA)1. Alzheime